IMSI or Standard ICSI? Which Sperm Problems Make the Choice Worth Discussing

If you are preparing for IVF in Thailand with a male-factor diagnosis, you may have seen IMSI listed as an optional laboratory step alongside standard ICSI. The names look similar and the two are often described together, which makes it hard to tell whether IMSI is a different treatment, a refinement of ICSI, or simply a marketing label. This guide sets out what actually changes, which sperm findings make the question worth raising, and where the evidence stops.

The short answer

IMSI (intracytoplasmic morphologic sperm injection) is a way of choosing which sperm to inject. It uses very high magnification microscopy — above 6000x according to the UK regulator’s patient guidance — to inspect sperm shape in more detail before a single sperm is selected for ICSI. The injection step itself is standard ICSI. So IMSI does not change how fertilisation is attempted, and it does not change whether embryos are tested.

That distinction matters for your decision. IMSI is best understood as a sperm-selection add-on that a clinician may consider for particular male-factor pictures, not as a separate fertility treatment with its own success profile. The same HFEA guidance reports that the reviewed evidence is not strong enough to say whether IMSI improves the chance of having a baby, including in male-factor infertility, and that the evidence reviewed does not support using IMSI over standard ICSI. In other words, the case for IMSI rests on laboratory reasoning and clinical judgement, not on established improvement in live birth.

What IMSI changes, and what it does not

Standard ICSI selects a sperm under ordinary laboratory magnification and injects it into an egg. IMSI adds a higher-magnification inspection step before that selection. Everything downstream — fertilisation, embryo development, any planned genetic testing of embryos, transfer — follows the same path.

• Changes: the magnification and criteria used when a sperm is chosen.
• Does not change: the injection technique, the number of eggs retrieved, the fertilisation method, embryo testing, or the underlying cause of the male-factor diagnosis.
• Does not fix: a sperm production problem, a genetic cause, or DNA damage inside the sperm head. Selecting a sperm that looks better under high magnification is not the same as proving that sperm is functionally better.

This is why the honest framing is “selection refinement with uncertain benefit” rather than “upgrade”. If a clinic presents IMSI as a way to improve embryo quality or guarantee a healthier pregnancy, that claim goes beyond what the published evidence supports.

Which sperm problems make IMSI worth discussing

There is no single sperm result that automatically makes IMSI the right choice. The situations below are the ones where clinicians most often raise the question, because each involves either very few normally shaped sperm to choose from or a history that standard ICSI has not resolved. Treat this as a map of the conversation, not a list of indications that apply to you.

Predominantly abnormal morphology (teratozoospermia)

When most sperm in a sample have abnormal shape, the pool of normally formed sperm available for selection is small. The logic behind IMSI is that higher magnification may help the embryologist identify the better-formed sperm within that limited pool. Whether that translates into a better outcome is exactly what the evidence has not settled. If your report describes severe teratozoospermia, this is a reasonable point to ask your clinician how they would weigh IMSI against standard ICSI for your sample.

Severe oligozoospermia with few motile, normally formed sperm

Where sperm concentration is very low, the practical constraint is the number of usable sperm, not the magnification used to inspect them. IMSI cannot create more sperm. It may be discussed when there are still enough motile, normally formed sperm to make a selection step meaningful, but in very severe cases the limiting factor is the sample itself. Ask directly whether your sample gives the laboratory a realistic choice to make.

High sperm DNA fragmentation

Sperm DNA fragmentation is a separate measure from shape and is usually assessed with a dedicated test rather than routine semen analysis. It is often raised in discussions about IMSI because the hope is that better-looking sperm also carry less DNA damage. That link is not established by the evidence summarised here, and a high fragmentation result does not by itself make IMSI the answer. It is a finding to discuss with your clinician, including whether any underlying cause should be addressed first.

Repeated ICSI fertilisation or implantation failure

When previous ICSI cycles have produced poor fertilisation or repeated implantation failure without a clear explanation, couples often look for something to change in the laboratory. IMSI is sometimes raised in that situation. Be aware that “we changed the sperm selection method” is not evidence that the change caused a different outcome, and a history of failed cycles usually deserves a broader review — the stimulation protocol, the embryology record, the uterine assessment and any genetic testing already done — rather than a single add-on.

Surgically retrieved sperm

When sperm are retrieved surgically, the numbers available are often limited and the sample may contain fewer motile, normally formed sperm. This is a setting where the selection step can feel especially consequential, and where clinicians may discuss IMSI. Whether it helps is again a judgement call rather than an established benefit, and the practical question is whether the retrieved sample offers enough to select from.

Where IMSI adds little over standard ICSI

For many male-factor cases, standard ICSI already addresses the core problem: getting a sperm into the egg when sperm numbers, movement or shape make natural fertilisation unlikely. If your semen analysis shows mild abnormalities, or if the male factor is not the main reason for IVF, there is little laboratory rationale for adding a high-magnification selection step, and the evidence does not support routine use over standard ICSI. The same applies when the limiting factor is egg number or embryo development rather than sperm selection.

A useful way to think about it: IMSI is a question about the choice of sperm, so it only becomes interesting when that choice is genuinely constrained or when previous cycles suggest the standard approach has not worked.

A comparison you can take to a consultation

The table below sets out the decision criteria side by side. It is a framework for your discussion, not a recommendation for either option.

Criterion	Standard ICSI	IMSI
What it is	Injection of a selected sperm into an egg	Standard ICSI with a higher-magnification sperm-selection step beforehand
Main male-factor situations discussed	Broad range of sperm problems where natural fertilisation is unlikely	Severe morphology problems, very low usable sperm numbers, high DNA fragmentation, repeated ICSI failure, surgically retrieved sperm
Evidence for improved live birth	Established as a treatment route for male-factor infertility	Not established; reviewed evidence does not support IMSI over standard ICSI
What it cannot change	The underlying cause of the male factor	The underlying cause, the injection method, or embryo testing decisions
Practical questions	Is ICSI appropriate for our diagnosis?	Does this laboratory perform IMSI, how often, and is it included or charged separately?

How IMSI interacts with planned PGT

If you are also considering preimplantation genetic testing, keep the two decisions separate. PGT examines embryos — for chromosome number (PGT-A), a known monogenic condition (PGT-M) or a structural rearrangement (PGT-SR) — after fertilisation and development. IMSI acts earlier, at sperm selection. Neither replaces the other, and choosing IMSI does not make PGT more or less appropriate, nor does planning PGT make IMSI necessary.

What can connect them is the reason for testing. If PGT is being considered because of a known genetic cause in the family, that is a separate clinical pathway from sperm selection. If it is being considered after repeated loss or failed cycles, the same broader review applies. It is worth asking your clinician to explain, in one conversation, what each test or step is meant to answer — and what it would not tell you. Our guide to PGT for male factor infertility covers where testing helps and where it does not.

What the evidence can and cannot settle

The most useful thing you can bring to this decision is a clear sense of what is known. The HFEA’s assessment of IMSI is a good benchmark: it describes the technique, reports insufficient moderate- or high-quality evidence to rate whether IMSI improves the chance of having a baby, and states that the reviewed evidence does not support using IMSI over standard ICSI. That does not mean IMSI is harmful or forbidden; it means the benefit is unproven, so the decision belongs with a clinician who can weigh your specific sample, history and laboratory.

Be cautious with any source — including a clinic’s own material — that presents IMSI as proven to improve success rates, embryo quality or child health. Those claims are not supported by the evidence summarised here. Equally, a clinic that offers IMSI is not doing anything wrong; it is offering an add-on whose value is debated.

Questions to bring to your clinician

These are clinical questions, and your treating clinician is the right person to answer them. A coordinator can help you organise the questions and the records, but cannot diagnose or advise on treatment.

1. Looking at my semen analysis and history, is there a specific reason to consider IMSI, or would standard ICSI be the default?
2. Does this laboratory perform IMSI in-house, and how often does it carry out the procedure?
3. Is IMSI included in the quoted cycle cost or charged as a separate add-on? What exactly does the quote cover?
4. What would you expect IMSI to change in our case, and what would it not change?
5. If we are planning PGT, does the IMSI decision affect the testing plan in any way?
6. If a previous ICSI cycle did not work, what else should be reviewed before adding a laboratory step?

If you are still at the stage of gathering records, our guide to male-factor fertility records to prepare before IVF lists the documents that make these conversations more productive. For the wider picture of what IVF involves with a male-factor diagnosis, see IVF for male factor infertility in Thailand.

Practical preparation before you decide

IMSI is usually decided close to the laboratory stage, but the groundwork happens earlier. Three things make the conversation easier:

• A current, complete semen analysis with the parameters your clinician will actually use, plus any DNA fragmentation result if one has been done.
• A clear cycle history — how many previous ICSI cycles, fertilisation rates, embryo development and transfer outcomes — if you have had treatment before.
• A written cost comparison that separates the standard cycle from optional laboratory add-ons, so you can see what IMSI would add and whether it is bundled.

If you would like help pulling these together, or want your questions and records organised before a remote consultation with a Thai hospital, you can request a case review. The coordination service can help with records, appointment requests and language needs; the clinical judgement about IMSI stays with your treating clinician.

Frequently asked questions

Does IMSI improve the chance of a baby compared with standard ICSI?

The published evidence does not establish that it does. The HFEA reports insufficient moderate- or high-quality evidence to rate whether IMSI improves the chance of having a baby, including in male-factor infertility, and states that the reviewed evidence does not support using IMSI over standard ICSI. A clinician may still consider it for a specific case, but that is a judgement call rather than a proven benefit.

If I have high sperm DNA fragmentation, should I choose IMSI?

That is a clinical question for your treating clinician. High DNA fragmentation is one of the findings often discussed alongside IMSI, but the evidence summarised here does not establish that IMSI corrects DNA damage or improves outcomes. It is worth asking whether an underlying cause should be reviewed first and what the clinician expects IMSI to change in your case.